| Literature DB >> 35399945 |
Dongze Chen1, Hanyu Wu2, Xinpei Wang1, Tao Huang3,4, Jinzhu Jia1,5.
Abstract
Background: Epidemiological investigations have established unhealthy lifestyles, such as excessive leisurely sedentary behavior (especially TV/television watching) and breakfast skipping, increase the risk of type 2 diabetes (T2D), but the causal relationship is unclear. We aimed to understand how single nucleotide variants contribute to the co-occurrence of unhealthy lifestyles and T2D, thereby providing meaningful insights into disease mechanisms.Entities:
Keywords: Mendelian randomization; TV watching; breakfast skipping; genome genetic correlation; type 2 diabetes
Mesh:
Year: 2022 PMID: 35399945 PMCID: PMC8988136 DOI: 10.3389/fendo.2022.836023
Source DB: PubMed Journal: Front Endocrinol (Lausanne) ISSN: 1664-2392 Impact factor: 5.555
Figure 1Conceptual diagram of Mendelian randomization and mediation analysis. (A) Mendelian randomization is based on the following three assumptions. (1) Genetic variants are strongly associated with exposure (p<5×10-8); (2) instrumental variables can only act on the outcome through exposure, and there is no direct association with the outcome; and (3) instrumental variables are independent of any confounding factors. In this situation, c represents the total effect, SNV: single nucleotide variant. (B) Two-step Mendelian randomization, where a represents the effect of the exposure on the mediator; b represents the effect of mediator on the outcome; c’ represents the direct effect; and a and b are estimated separately using separate genetic instrumental variables for both the exposure and mediator. These estimates are then multiplied together to estimate the indirect effect of the mediator (a * b), and the direct effect c’ = c – a*b.
Genetic correlation of type 2 diabetes with TV watching and breakfast skipping, estimated by high-definition likelihood method (HDL-method) and linkage disequilibrium score regression (LDSC).
| Method | Trait |
| SE |
| pvalue | h^2(SE) |
|---|---|---|---|---|---|---|
|
| TV watching | 0.26 | 0.023 | 0.21 to 0.31 | 1.63E-29 | 0.13(0.004) |
| breakfast skipping | 0.15 | 0.032 | 0.09 to 0.21 | 2.02E-6 | 0.05(0.002) | |
|
| TV watching | 0.28 | 0.030 | 0.22 to 0.34 | 1.28E-21 | 0.13(0.004) |
| breakfast skipping | 0.14 | 0.043 | 0.06 to 0.22 | 1.30E-3 | 0.05(0.003) |
Summary statistics for each trait were merged with Hapmap3 SNPs excluding the HLA region to estimate rg; p value < 0.05/2;
h^2 indicates the heritability of the corresponding phenotype.
Figure 2Numbers of significant genes related to TV watching and breakfast skipping and the number of shared genes with T2D. Significant genes were identified by P Bonferroni < 0.05. GTEx, genotype-tissue expression project; GWAS, genome-wide association studies; TWAS, transcriptome-wide association study; NSTSG, Number of shared TWAS significant genes between traits; T2D: type 2 diabetes. (A) No. of TWAS Significant Genes for TV watching and No. of Overlapped Genes with T2D. (B) No. of TWAS Significant Genes for breakfast skipping and No. of Overlapped Genes with T2D.
Figure 3Flowcharts visualizing the process for instrument definition, extraction and harmonization for the two-sample MR analyses conducted in the present study.
Causal relationships between TV watching, skipping breakfast and T2D (findings adjusted for multiple comparisons).
| Exposure | Outcome | N_snp | Method | beta | OR | 95%CI# | SE | p_value | Heterogeneity_P_value | Intercept_P_value | Steiger_P_value |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
| T2D | 127 | IVW | 0.629 | 1.86 | (1.54,2.26) | 0.098 |
| 1.66E-05 | NA | 1.12E-168 |
| WM | 0.599 | 1.82 | (1.44,2.3) | 0.12 |
| NA | NA | ||||
| MR–Egger | 0.253 | 1.29 | (0.52,3.17) | 0.46 | 5.83E-01 | 1.60E-05 | 0.41 | ||||
| MR-RAPS | 0.577 | 1.78 | (1.5,2.11) | 0.087 |
| NA | NA | ||||
| MR-PRESSO:raw | 0.569 | 1.77 | (1.49,2.09) | 0.086 |
| NA | NA | ||||
| MR-PRESSO : Outlier-corrected | 0.609 | 1.84 | (1.56,2.16) | 0.083 |
| NA | NA | ||||
|
| T2D | 5 | IVW | 0.232 | 1.26 | (0.51,3.14) | 0.465 | 6.18E-01 | 0.11 | NA | 3.67E-16 |
| WM | 0.752 | 2.12 | (0.89,5.07) | 0.444 | 8.99E-02 | NA | NA | ||||
| MR–Egger | 2.111 | 8.25 | (0.31,219.57) | 1.674 | 2.97E-01 | 0.16 | 0.33 | ||||
| MR-RAPS | 0.255 | 1.29 | (0.63,2.67) | 0.37 | 4.90E-01 | NA | NA | ||||
| MR-PRESSO:raw | 0.239 | 1.27 | (0.6,2.69) | 0.383 | 5.61E-01 | NA | NA | ||||
| MR-PRESSO: Outlier-corrected | NA | NA | NA | NA | NA | NA | NA | ||||
|
| TV watching | 35 | IVW | -0.003 | NA | (-0.017 0.011) | 0.007 | 6.16E-01 | 3.04E-09 | NA | 2.87E-290 |
| WM | 0.001 | NA | (-0.011,0.013) | 0.006 | 8.79E-01 | NA | NA | ||||
| MR–Egger | 0.012 | NA | (-0.021,0.045) | 0.017 | 4.82E-01 | 4.78E-09 | 0.34 | ||||
| MR-RAPS | -0.002 | NA | (-0.016,0.012) | 0.007 | 7.55E-01 | NA | NA | ||||
| MR-PRESSO:raw | -0.002 | NA | (-0.014, 0.010) | 0.006 | 8.07E-01 | NA | NA | ||||
| MR-PRESSO: Outlier-corrected | -0.001 | NA | (-0.011, 0.009) | 0.005 | 8.85E-01 | NA | NA | ||||
|
| skipping breakfast | 34 | IVW | -0.002 | NA | (-0.016, 0.012) | 0.007 | 7.72E-01 | 1.29E-03 | NA | 1.28E-203 |
| WM | -0.001 | NA | (-0.017, 0.015) | 0.008 | 9.25E-01 | NA | NA | ||||
| MR–Egger | 0.009 | NA | (-0.024, 0.042) | 0.017 | 5.99E-01 | 1.15E-03 | 0.49 | ||||
| MR-RAPS | 0.004 | NA | (-0.010, 0.018) | 0.007 | 5.24E-01 | NA | NA | ||||
| MR-PRESSO:raw | 0.002 | NA | (-0.010,0.014) | 0.006 | 7.58E-01 | NA | NA | ||||
| MR-PRESSO : Outlier-corrected | -0.001 | NA | (-0.013,0.011) | 0.006 | 9.08E-01 | NA | NA |
T2D, type 2 diabetes; CI, confidence interval; IVW, inverse variance weighted; MR, Mendelian randomization; NA, not applicable; N_snp: number of instrumental variables; OR, odds ratio; SE, standard error; SNP, single nucleotide polymorphism; WM, weighted median. When T2D is used as the outcome, there is an OR value.
: 95% CIs of ORs are presented for the analysis of T2D as outcome, while 95% CIs of β values are presented for the analysis of the other outcomes.
p_value in bold refers to achieving statistical significance (p_value < 0.05/6).
The association between TV watching and risk of type 2 diabetes after remove 16 SNPs associated with confounding traits.
| Exposure | Outcome | N_snp | Method | beta | OR | CI | SE | p_value | Heterogeneity_P_value | Intercept_P_value | Steiger_P_value |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
| 111 | IVW | 0.66 | 1.94 | (1.6,2.36) | 0.1 | 3.74E-11 | 1.66E-05 | NA | 1.1E-168 |
| 111 | WM | 0.59 | 1.82 | (1.41,2.35) | 0.129 | 3.27E-06 | NA | NA | 1.1E-168 | ||
| 111 | MR Egger | 0.60 | 1.83 | (0.71,4.69) | 0.481 | 0.21 | 1.60E-05 | 0.41 | 1.1E-168 | ||
| 111 | MR-RAPS | 0.58 | 1.78 | (1.5,2.11) | 0.087 | 3.13E-11 | NA | NA | 1.1E-168 | ||
| 111 | MR-PRESSO:raw | 0.57 | 1.77 | (1.49,2.09) | 0.086 | 6.07E-10 | NA | NA | 1.1E-168 | ||
| 111 | MR-PRESSO: Outlier-corrected | 0.61 | 1.84 | (1.56,2.16) | 0.083 | 1.22E-11 | NA | NA | 1.1E-168 |
T2D, type 2 diabetes; CI, confidence interval; IVW, inverse variance weighted; MR, Mendelian randomization; NA, not applicable; N_snp, number of instrumental variables; OR, odds ratio; SE, standard error; SNP, single nucleotide polymorphism; WM, weighted median. When T2D is used as the outcome, there is an OR value.
Two-step Mendelian randomization mediation analysis of the association between TV watching (exposure) and type 2 diabetes (outcome).
| Mediator | Exposure → Mediator | Mediator → Outcome | Indirect causal effect by coefficient product | Direct causal effect | Adjust OR | Proportion of mediation | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| IVW causal effect | IVW p value | MR Egger Intercept p value | IVW causal effect | IVW p value | MR Egger Intercept p value | |||||
|
| 0.315 |
| 0.195 | 0.581 |
| 0.563 | 0.183 | 0.439 | 1.55 | 29.10% |
|
| 0.112 | 1.08E-01 | 0.119 | -0.1 | 4.21E-02 | 0.307 | NA | NA | NA | NA |
|
| 0.24 |
| 0.207 | 0.106 | 1.61E-01 | 0.028 | NA | NA | NA | NA |
|
| -0.289 |
| 0.002 | -0.213 |
| 0.008 | 0.062 | 0.561 | 1.75 | 9.86% |
|
| 0.171 | 6.58E-03 | 0.197 | -0.033 | 4.96E-01 | 0.344 | NA | NA | NA | NA |
|
| 0.053 |
| 0.589 | 1.602 |
| 0.015 | 0.085 | 0.537 | 1.71 | 13.51% |
|
| 0.088 |
| 0.898 | 1.318 | 6.19E-02 | 0.253 | NA | NA | NA | NA |
|
| 0.074 |
| 0.862 | -2.595 | 1.76E-01 | 0.221 | NA | NA | NA | NA |
|
| 0.176 |
| 0.596 | 0.346 | 2.03E-01 | 0.405 | NA | NA | NA | NA |
|
| 0.063 | 3.16E-01 | 0.506 | 0.921 | 1.78E-02 | 0.823 | NA | NA | NA | NA |
|
| 0.038 |
| 0.944 | 1.223 |
| 0.183 | 0.046 | 0.576 | 1.78 | 7.31% |
|
| NA | NA | NA | NA | NA | NA | 0.376 | 0.253 | 1.29 | 59.78% |
BMI, body mass index; TC, total cholesterol; TG, triglyceride; HDL, high density lipoprotein; LDL, low density lipoprotein; FG, fasting glucose; FI, fasting insulin; HOMA-β, homeostatic model assessment of beta cell function; HOMA-IR, homeostatic model assessment of insulin resistance; 2hGlu, 2-h postprandial glucose; HbA1c, hemoglobin; NA, not applicable; The IVW causal effect size was the beta coefficient estimated by IVW models for corresponding outcome; Direct causal effect: this value is obtained by subtracting the indirect effect from 0.629 as show in ; IVW p values < 0.05/11 indicate statistical significance and are marked in bold font, and mediation analysis is significant only if both MR steps reach statistical significance; Proportion of mediation = Indirect causal effect by coefficient product/0.629.
Cross-trait meta-analysis results between type 2 diabetes and television watching (P meta < 2.5×10-8 and single-trait P < 1×10-5).
| Index.SNP | CHR | Genome position | EA | NEA | EAF | T2D | TV watching |
| Genes | variant annotation | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BETA | P | BETA | P | |||||||||
|
| 19 | 19q13.32 | A | G | 0.84 | 0.110 | 1.50E-09 | 0.014 | 3.60E-07 | 2.42E-14 | [APOC1,APOE,PVRL2,TOMM40] | downstream |
|
| 6 | 6q22.32 | T | C | 0.48 | 0.073 | 4.40E-09 | 0.010 | 1.50E-06 | 7.64E-14 | [CENPW] | intron |
|
| 11 | 11q13.4 | T | C | 0.86 | -0.095 | 5.80E-09 | -0.014 | 3.50E-06 | 3.84E-13 | [ARAP1,ATG16L2,FCHSD2,MIR4692,STARD10] | intron |
|
| 2 | 2p16.1 | A | G | 0.55 | 0.066 | 3.90E-08 | 0.011 | 1.00E-06 | 4.39E-12 | [AC007381.3]* | upstream |
|
| 12 | 12q14.3 | A | T | 0.88 | -0.110 | 1.60E-07 | -0.016 | 7.40E-06 | 1.23E-11 | [HMGA2,RPSAP52] | intron |
|
| 12 | 12q14.3 | T | C | 0.57 | -0.067 | 1.70E-07 | -0.010 | 9.60E-06 | 1.34E-10 | [HMGA2]* | intergenic |
|
| 9 | 9q34.2 | T | C | 0.76 | 0.065 | 3.40E-06 | 0.012 | 3.00E-06 | 1.81E-09 | [ABO] | intron |
|
| 11 | 11q13.1 | A | G | 0.82 | 0.069 | 5.80E-06 | 0.013 | 3.90E-06 | 2.68E-09 | [CFL1]* | intergenic |
EA, effect allele; NEA, noneffect allele; Pmeta is the cross-trait meta-analysis P value. CHR, chromosome; T2D, type 2 diabetes; genes in * are the nearest genes to this locus.